Biometric Identification and Cybersecurity Software Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference at 11:30am ET, Jan. 28 in Atlantic City, NJ
BIO-key (NASDAQ:BKYI) will present at the DealFlow Discovery investor conference at the Borgata in Atlantic City on Jan. 28–29, 2026.
Rhea-AI Summary
BIO-key (NASDAQ:BKYI) will present at the DealFlow Discovery investor conference at the Borgata in Atlantic City on Jan. 28–29, 2026. CEO Mike DePasquale is scheduled to present on Jan. 28 at 11:30am ET in Room 1 and will be available for 1-on-1 investor meetings during the event. Institutional investors, family offices, and high-net-worth investors may register at no cost. Presentation materials will be posted on the DealFlow Discovery website in January and registration is available online.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BKYI
In the Jan 13 session, BKYI declined 4.09%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference dates
- January 28–29, 2026
- DealFlow Discovery Conference schedule at Borgata hotel
- Presentation time
- 11:30 am ET
- BIO-key CEO presentation slot on January 28
- Presentation room
- Room 1
- Location of BIO-key’s DealFlow conference session
- Price change
- 4.62%
- BKYI move over prior 24 hours before this news
- 52-week range
- $0.5088–$3.68
- Low and high before this announcement
- Market cap
- $6,209,382
- Equity value prior to conference news
Historical Context
-
Announced upcoming DealFlow Discovery investor conference appearance.
-
Showcased new passwordless authentication innovations at Gartner IAM Summit.
-
Partnered with SAVIS Group to distribute biometric solutions in Vietnam.
-
Reported lower year-over-year revenue and a quarterly net loss.
-
Teamed with VaporVM to expand IAM and biometric reach in MEA.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
biometric technical
identity and access management technical
saas technical
passwordless technical
phish-resistant authentication technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
ATLANTIC CITY & HOLMDEL, NJ / ACCESS Newswire / January 13, 2026 / BIO-key® International, Inc. (NASDAQ:BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant authentication, will participate at the DealFlow Discovery Conference Wednesday and Thursday, January 28th and 29th at the Borgata hotel in Atlantic City, New Jersey. Institutional investors, family offices and high-net-worth investors are invited to attend at no cost.
BIO-key CEO Mike DePasquale will present on Wednesday at 11:30 am ET in Room 1 and will be available for 1-on-1 meetings throughout the event. BIO-key's presentation details will be posted on DealFlow's website in January.
Registration:
Click here: https://dealflowdiscoveryconference.com/registration/ to register for the Discovery Conference.
About The DealFlow Discovery (www.dealflowdiscoveryconference.com)
The DealFlow Discovery Conference is where high-growth companies come to be discovered. Formerly known as The Microcap Conference, the event has been expanded to include both publicly traded microcaps and qualified private companies across a variety of high-growth sectors.
Organized by DealFlow Events, the conference brings together hundreds of companies, investors, and dealmakers for two days of company presentations, expert discussions on raising capital, unlimited 1-on-1 meetings, interactive sessions and networking opportunities. The Discovery Conference delivers a high visibility platform for companies to showcase their value propositions to a broad base of prospective investors.
Keynote presentations and panel discussions led by renowned industry figures will provide insights on business, investing, entrepreneurial success, and other trends in US equity markets, from capital formation to regulatory updates, tailored to the public microcap and private market communities.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-key:
LinkedIn - Corporate: https://www.linkedin.com/company/bio-key-international
X - Corporate: @BIOkeyIntl
X - Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
SOURCE: DealFlow Events
View the original press release on ACCESS Newswire